Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group

Lieke H J Simkens, Harm van Tinteren, Anne May, Albert J ten Tije, Geert-Jan M Creemers, Olaf J L Loosveld, Felix E de Jongh, Frans L G Erdkamp, Zoran Erjavec, Adelheid M E van der Torren, Jolien Tol, Hans J J Braun, Peter Nieboer, Jacobus J M van der Hoeven, Janny G Haasjes, Rob L H Jansen, Jaap Wals, Annemieke Cats, Veerle A Derleyn, Aafke H HonkoopLinda Mol, Cornelis J A Punt, Miriam Koopman

Research output: Contribution to journal › Article › Academic › peer-review

Fingerprint

Dive into the research topics of 'Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group'. Together they form a unique fingerprint.

Medicine & Life Sciences